Subscribe to SciBX Today

Welcome to SciBX

SciBX is a new weekly publication from Nature Publishing Group and BioCentury that provides a timely, concise and understandable analysis of the scientific content and commercial potential of the most important translational research papers from across the life science literature.

So if you want to efficiently identify and evaluate new science and technology developments that have commercial and investment potential, or if you want to quickly and efficiently identify key translational research papers or improve your understanding of the commercial goals and problem areas in translational research, you should become a subscriber today.

SciBX is available in the following formats

• For individual and group subscribers, SciBX is available as a weekly PDF delivered direct to your e-mail account. Subscribe
• For institutional subscribers, SciBX is available as a full-text html site through the purchase of a site-wide licence. For corporate institutions, subscribe. For academic and government institutions, subscribe.

Each week this unique publication will combine the business intelligence of BioCentury and the scientific acumen of Nature Publishing Group. So if you're serious about translating science into medicines, then you need SciBX.